Cargando...

Antiproliferative effects of somatostatin analogs in endocrine tumours

Somatostatin has been discovered as a somatotroph release inhibitory factor (SRIF), and it has been demonstrated that SRIF and its analogs can inhibit hormone secretion and control the neoplastic bulk of several endocrine tumours. In vitro studies have contributed to the current knowledge of the mec...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Zatelli, Maria Chiara
Formato: Artigo
Lenguaje:Inglês
Publicado: Medicine Reports Ltd 2009
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2924708/
https://ncbi.nlm.nih.gov/pubmed/20948740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3410/M1-40
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!